Back to Search Start Over

Patient costs for buprenorphine influence engagement in treatment.

Authors :
Enos, Gary
Source :
Alcoholism & Drug Abuse Weekly; 8/21/2023, Vol. 35 Issue 33, p1-8, 8p
Publication Year :
2023

Abstract

Newly published research has uncovered a strong association between patients' out‐of‐pocket costs for buprenorphine and the likelihood that they will keep using the medication for opioid use disorder (OUD). The study, involving privately insured individuals who initiated buprenorphine treatment between 2013 and 2020, also showed a disappointingly low rate of one‐year continuation of the treatment overall. [ABSTRACT FROM AUTHOR]

Subjects

Subjects :
NARCOTICS
HEALTH policy
SUBSTANCE abuse
BUPRENORPHINE
MEDICAL care costs
PREVENTIVE health services
DRUGS
HEALTH insurance
TERMINATION of treatment
PATIENT compliance
PATIENT Protection & Affordable Care Act

Details

Language :
English
ISSN :
10421394
Volume :
35
Issue :
33
Database :
Complementary Index
Journal :
Alcoholism & Drug Abuse Weekly
Publication Type :
Periodical
Accession number :
170027675
Full Text :
https://doi.org/10.1002/adaw.33868
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details